Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “γδ T Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02585908
What this trial is testing

Safety and Efficacy of γδ T Cell Against Gastric Cancer

Who this might be right for
Gastric Cancer
Beijing Doing Biomedical Co., Ltd. 120
Very early researchLooking for participantsNCT07126782
What this trial is testing

The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT

Who this might be right for
AML (Acute Myelogenous Leukemia)AML
Institute of Hematology & Blood Diseases Hospital, China 10
Early research (Phase 1)Ended earlyNCT02781805
What this trial is testing

Pilot Study of Bisphosphonates for Breast Cancer

Who this might be right for
Breast Neoplasms
University of Wisconsin, Madison 6
Not applicableNot Yet RecruitingNCT07204496
What this trial is testing

A Clinical Study on the Safety, Tolerance, and Preliminary Efficacy of γδ-T Cell Injection in the Treatment of Advanced Bladder Cancer

Who this might be right for
Advanced Bladder Cancer
Shanghai 10th People's Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03183219
What this trial is testing

Safety and Efficiency of γδ T Cell Against Liver Cancer

Who this might be right for
Liver Cancer
Fuda Cancer Hospital, Guangzhou 30
Testing effectiveness (Phase 2)Study completedNCT03180437
What this trial is testing

Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou 62
Very early researchUnknownNCT04696705
What this trial is testing

Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Peripheral T Cell Lymphoma (PTCL)
Institute of Hematology & Blood Diseases Hospital, China 10
Early research (Phase 1)UnknownNCT04107142
What this trial is testing

Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour

Who this might be right for
Colorectal CancerTriple Negative Breast CancerSarcoma+3 more
CytoMed Therapeutics Pte Ltd 10
Very early researchUnknownNCT04518774
What this trial is testing

Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Beijing 302 Hospital 8
Early research (Phase 1)Not Yet RecruitingNCT07120607
What this trial is testing

Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia

Who this might be right for
Leukemia
Anhui Provincial Hospital 9
Very early researchUnknownNCT04702841
What this trial is testing

CAR - γ δ T Cells in the Treatment of Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors

Who this might be right for
CARMalignant Tumors
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 8
Not applicableActive Not RecruitingNCT04911478
What this trial is testing

Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells

Who this might be right for
Lymphoma, FollicularLymphoma, Mantle-CellMarginal Zone Lymphoma+3 more
Adicet Therapeutics 50
Not applicableLooking for participantsNCT07680816
What this trial is testing

Metabolic and Functional Study of γδ T Cells in Critically Ill Patients

Who this might be right for
SepsisCritical IllnessImmunosuppression+4 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 105
Very early researchNot Yet RecruitingNCT07535138
What this trial is testing

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)IgA Nephropathy (IgAN)
Air Force Military Medical University, China 15
Testing effectiveness (Phase 2)Ended earlyNCT02459067
What this trial is testing

ImmuniCell® in Patients With Advanced Cancers

Who this might be right for
Malignant MelanomaNon-small Cell Lung CancerRenal Cell Cancer
TC Biopharm 8
Testing effectiveness (Phase 2)Study completedNCT03183206
What this trial is testing

Safety and Efficiency of γδ T Cell Against Breast Cancer

Who this might be right for
Breast Cancer
Fuda Cancer Hospital, Guangzhou 100
Testing effectiveness (Phase 2)UnknownNCT04764513
What this trial is testing

Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndromes+1 more
Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03339661
What this trial is testing

Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T Cells Immunomonitoring.

Who this might be right for
Kidney Transplant Infection
University Hospital, Bordeaux 38
Early research (Phase 1)Looking for participantsNCT07100873
What this trial is testing

ADI-001 in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
Adicet Therapeutics 25
Early research (Phase 1)Not Yet RecruitingNCT07491263
What this trial is testing

Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia

Who this might be right for
Relapsed/Refractory CD19-positive B-ALL
Fujian Medical University 6
Next Page